Chemoinformaics analysis of 7-(2,4-Hexadiynylidene)-1,6-dioxaspiro[4,4]nona-2,8-diene
| Molecular Weight | 204.269 | nRot | 2 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 13 |
| Exact Molecular Weight | 204.115 | nRing | 2 |
| Solubility: LogS | -1.944 | nHRing | 2 |
| Solubility: LogP | 1.342 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 33.9827 |
| nHD | 0 | BPOL | 19.5233 |
| QED | 0.508 |
| Synth | 5.087 |
| Natural Product Likeliness | 2.065 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.005 |
| HIA | 0.006 |
| CACO-2 | -4.454 |
| MDCK | 0.0000347 |
| BBB | 0.957 |
| PPB | 0.832944 |
| VDSS | 0.651 |
| FU | 0.118657 |
| CYP1A2-inh | 0.51 |
| CYP1A2-sub | 0.767 |
| CYP2c19-inh | 0.714 |
| CYP2c19-sub | 0.863 |
| CYP2c9-inh | 0.134 |
| CYP2c9-sub | 0.963 |
| CYP2d6-inh | 0.843 |
| CYP2d6-sub | 0.939 |
| CYP3a4-inh | 0.639 |
| CYP3a4-sub | 0.238 |
| CL | 4.591 |
| T12 | 0.388 |
| hERG | 0.064 |
| Ames | 0.28 |
| ROA | 0.091 |
| SkinSen | 0.912 |
| Carcinogencity | 0.907 |
| EI | 0.286 |
| Respiratory | 0.655 |
| NR-Aromatase | 0.056 |
| Antiviral | Yes |
| Prediction | 0.603212 |